Similar articles

• Inadequate immune response among public safety workers receiving intradermal vaccination against hepatitis B--United States, 1990-1991.

  Centers for Disease Control (CDC). Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep. 1991 Aug 23;40(33):569-72. MMWR Morb Mortal Wkly Rep. 1991. PMID: 1830921
• [Results of an anti-hepatitis-B vaccination in a population at risk].

  Stellato M, Carbi S, Tosolini S. Stellato M, et al. Boll Ist Sieroter Milan. 1989;68(1):34-41. Boll Ist Sieroter Milan. 1989. PMID: 2535244 Italian.
• [Active vaccination against hepatitis-B virus infection in thalassemia].

  Goldfarb A, Shouval S, Mani N, Shraga S, Rachmilewitz E. Goldfarb A, et al. Harefuah. 1986 Nov 16;111(10):273-7. Harefuah. 1986. PMID: 2950034 Hebrew. No abstract available.
• [Hepatitis B at an open institution for the mentally retarded. Immunogenic effect of a recombinant anti-hepatitis-B vaccine].

  García O, Bruguera M, Mayor A, Sánchez-Tapias JM, Vall O, Rodés J. García O, et al. Enferm Infecc Microbiol Clin. 1990 Mar;8(3):148-52. Enferm Infecc Microbiol Clin. 1990. PMID: 2151250 Review. Spanish.
• Hepatitis B vaccination in hemophiliacs.

  Mannucci PM. Mannucci PM. Prog Clin Biol Res. 1990;324:113-21. Prog Clin Biol Res. 1990. PMID: 2137930 Review. No abstract available.